All-trans retinoic acid and protein kinase C α/β1 inhibitor combined treatment targets cancer stem cells and impairs breast tumor progression

por Damian Emilio Berardi, Lizeth Ariza Bareño, Natalia Amigo, Luciana Cañonero, Maria de las Nieves Pelagatti, Andrea Nora Motter, María Agustina Taruselli, María Inés Díaz Bessone, Stefano Martin Cirigliano, Alexis Edelstein, María Giselle Peters, Miriam Diament, Alejandro Jorge Urtreger, Laura Beatriz Todaro
Publicado 2021